Purobien Lifesciences Private Limited, a active private limited company, was established on 30 September 2019 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24290DL2019PTC355703. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 10 professional, Its leadership includes Vijay Kumar Aggarwal (Director), Pranshul Aggarwal (Director). Past directors included Rajesh Kumar Pandey, Pranshul Aggarwal. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Hall No. 2, First Floor, S-22, Badli Industrial Estate Phase 1, Delhi, Delhi, 110042.
U24290DL2019PTC355703
355703
30 September 2019
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Purobien Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijay Kumar Aggarwal | Director | 30 Sep 2019 | Current |
| Pranshul Aggarwal | Director | 17 Mar 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Mar 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Purobien Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.43% increase. The company also saw a substantial improvement in profitability, with a 23.22% increase in profit. The company's net worth Soared by an impressive increase of 16.64%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Purobien Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Purobien Lifesciences has a workforce of 10 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Purobien Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Purobien Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Purobien Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Purobien Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity Pranshul Aggarwal was appointed as a Director was appointed as a Director on 17 Mar 2021 & has been associated with this company since 4 years 9 months . was completed.
Vijay Kumar Aggarwal was appointed as a Director was appointed as a Director on 30 Sep 2019 & has been associated with this company since 6 years 2 months . was recorded as a recent event.
Purobien Lifesciences Private Limited was registered on 30 Sep 2019 with Roc Delhi & aged 6 years 2 months as per MCA records. was recorded as a recent event.
The CIN of Purobien Lifesciences Private Limited is U24290DL2019PTC355703.
Purobien Lifesciences Private Limited is headquartered at Hall No. 2, First Floor, S-22, Badli Industrial Estate Phase 1, Delhi, Delhi, 110042.
Purobien Lifesciences Private Limited was incorporated on 30 September 2019.
The current directors of Purobien Lifesciences Private Limited are
The primary industry of Purobien Lifesciences Private Limited is Manufacturing.
Purobien Lifesciences Private Limited is unlisted.
The authorized capital of Purobien Lifesciences Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Purobien Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX